Walden Biosciences Appoints Peter Guest Linde, M.D. as Chief Medical Officer
11. Oktober 2022 07:00 ET
|
Walden Biosciences, Inc.
CAMBRIDGE, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed biotechnology company focused on transforming the treatment of kidney disease, today...